在P2RX4中的多形态与2型糖尿病相关联:一项初步病例控制研究
Homa Noori1, Mahdi Majidpour2, Mahboobeh Sabeti Akbar-Abad3,4
1Department of Biology, Payame Noor University of Mashhad, Iran.
Nucleosides, nucleotides & nucleic acids
|July 2, 2024
概括
纯能受体的遗传变异与2型糖尿病 (T2DM) 有关. 在研究的人群中,rs25644A>G等位基因显著增加了T2DM风险.
科学领域:
- 遗传学和分子生物学
- 代谢疾病 代谢疾病
- 药物基因组学 药物基因组学
背景情况:
- 2型糖尿病 (T2DM) 是一种复杂的代谢障碍,具有不同的病因.
- purinergic受体涉及到各种生理过程,并被假设有助于T2DM病原体.
研究的目的:
- 调查纯能受体的遗传变异与T2DM风险之间的关联.
- 识别特定的基因标记物,这些标记物可能会影响特定人群中的T2DM易感性.
主要方法:
- 300名T2DM患者和300名健康对照者的基因定型使用放大阻断突变系统-聚合酶链反应 (ARMS-PCR).
- 使用SPSS V16.0.0.进行的统计分析.
- 分析包括等位基因和基因型频率,相互作用效应和单位基因型分析.
主要成果:
- rs25644A>G多态的G基因与T2DM风险增加显著相关 (OR = 1.51,95% CI = 1.14-1.99,p = 0.003).
- 这种关联在主要的基因型模型中观察到,表明在特定的基因型条件下风险增加.
- 在P2XR4基因中的基因型与rs1169727/rs25644亚型 (A/G) 之间的相互作用也增加了T2DM风险.
结论:
- rs25644A>G多态性在被研究人群中T2DM风险增加中起着重要作用.
- 纯能受体基因的遗传变异,特别是P2XR4,是T2DM发展的潜在贡献者.
- 需要进一步的研究来阐明这些遗传因素影响T2DM的确切机制.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Pathophysiology of Diabetes
918
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
918
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
Dipeptidyl Peptidase 4 Inhibitors
180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180


